ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag scientific misconduct genetics genomics neuroscience microbiology immunology

Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
A silver tree showing roots and branches in a circle on a blue background.
Onward and Upward!
Kristie Nybo, PhD | Sep 8, 2023 | 9 min read
At The Scientist, we are strengthening our roots while reaching for the sky.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Those We Lost in 2018
Ashley Yeager | Dec 26, 2018 | 10+ min read
The scientific community said goodbye to a number of leading researchers this year.
NIH Chief Varmus, In His Second Year, Credited With Reinvigorating Agency
Franklin Hoke | Feb 19, 1995 | 10+ min read
Questions remain about the low-key director's handling of clinical research, Congress, and scientific misconduct Not yet two years into his tenure as head of the National Institutes of Health, Harold E. Varmus is getting high marks from many scientists for his low-key, but thorough efforts to rejuvenate the agency's biomedical research effort. Initiatives to sharpen the basic science being done on campus and to streamline the peer review of proposals from outside researchers are bringing new
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Notebook
The Scientist Staff | Sep 1, 1997 | 7 min read
Table of Contents More Newsworthy Sheep Grade Strike Earns an F Brain Drain Sexual Chemistry Cheaper Journals Michign Misconduct Matters Lucky 7 Cloning BRCA2 Credit: Graham G. Ramsay ON THE LAMB: Dario Fauza performed fetal surgery on ovine patients. While Dolly the cloned sheep has yet to disappear from the headlines, other ovines have made medical history. Dario Fauza, a fellow at Harvard Medical School and Children's Hospital in Boston, along with Anthony Atala, an assistant professor of
2018 Top 10 Innovations
The Scientist | Dec 1, 2018 | 10+ min read
Biology happens on many levels, from ecosystems to electron transport chains. These tools may help spur discoveries at all of life's scales.

Run a Search

ADVERTISEMENT